Gibraltar Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Buy
498
+101
+25% +$103K 0.09% 96
2026
Q1
$365K Sell
397
-23
-5% -$23.3K 0.06% 102
2025
Q4
$451K Buy
+420
New +$402K 0.08% 94
2025
Q3
Sell
-391
Closed -$305K 115
2025
Q2
$305K Buy
391
+9
+2% +$6.99K 0.06% 95
2025
Q1
$316K Sell
382
-244
-39% -$203K 0.07% 88
2024
Q4
$483K Buy
626
+5
+0.8% +$4.14K 0.21% 36
2024
Q3
$550K Buy
+621
New +$558K 0.25% 34

Other funds holding LLY

Gibraltar Capital Management's LLY Position: Q2 2026 in Review

Gibraltar Capital Management increased its Eli Lilly (LLY) stake by 25% in Q2 2026, buying an estimated $103K and bringing the position to 498 shares worth $597K. The position accounts for 0.09% of the portfolio, ranked #96.

Gibraltar Capital Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. 1,123 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gibraltar Capital Management held 498 shares of Eli Lilly worth $597K as of Q2 2026.
  • Gibraltar Capital Management bought 101 Eli Lilly shares in Q2 2026, an estimated $103K.
  • Eli Lilly made up 0.09% of Gibraltar Capital Management's portfolio in Q2 2026, its #96 holding.
  • Gibraltar Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • 1,123 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gibraltar Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.